FDA Clearance Tracker · K242142
Fraxel® FTX Laser System
Last checked: Nov 20, 2026Latest source record: Aug 21, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Aug 21, 2024
Substantially Equivalent
Time to decision
30 days
Received Jul 22, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K242142
- Device name
- Fraxel® FTX Laser System
- Applicant
- Solta Medical
- Applicant location
- Bothell, WA
- Received
- Jul 22, 2024
- Decided
- Aug 21, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
- Third-party review
- Yes. An FDA-accredited third party reviewed this submission before FDA decided.
Device type
- Device type
- Powered Laser Surgical Instrument (GEX)
- Device class
- Class II
- Regulation
- 21 CFR 878.4810
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GEX. The earliest in FDA's data is K780585, decided Jul 19, 1978.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K242142
- The applicant filed a statement instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Solta Medical
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- CLEAR+BRILLIANT TOUCH® Laser SystemThird-party review510(k)
K223647 · Decided Dec 29, 2022 · 23 days after receipt
Device type: Powered Laser Surgical Instrument (GEX) · General & Plastic Surgery
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.